Aerospace & Defense
Build Your Comparison
Side-by-side financial analysisStock Comparison
VVX vs DLB vs JPM vs KO vs BAC
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Banks - Diversified
Beverages - Non-Alcoholic
Banks - Diversified
VVX vs DLB vs JPM vs KO vs BAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Aerospace & Defense | Information Technology Services | Banks - Diversified | Beverages - Non-Alcoholic | Banks - Diversified |
| Market Cap | $2.84B | $5.02B | $896.00B | $355.61B | $422.78B |
| Revenue (TTM) | $4.72B | $1.34B | $280.33B | $49.28B | $191.57B |
| Net Income (TTM) | $89M | $241M | $57.05B | $13.70B | $30.51B |
| Gross Margin | 8.5% | 87.9% | 60.0% | 61.7% | 56.1% |
| Operating Margin | 4.3% | 18.8% | 25.9% | 29.3% | 19.7% |
| Forward P/E | 14.9x | 12.2x | 14.4x | 25.3x | 12.6x |
| Total Debt | $1.17B | $39M | $942.38B | $45.49B | $365.90B |
| Cash & Equiv. | $369M | $702M | $343.34B | $10.27B | $231.84B |
VVX vs DLB vs JPM vs KO vs BAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| V2X, Inc. (VVX) | 100 | 184.8 | +84.8% |
| Dolby Laboratories,… (DLB) | 100 | 79.7 | -20.3% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| The Coca-Cola Compa… (KO) | 100 | 184.9 | +84.9% |
| Bank of America Cor… (BAC) | 100 | 235.9 | +135.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VVX vs DLB vs JPM vs KO vs BAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VVX ranks third and is worth considering specifically for growth exposure.
- Rev growth 3.7%, EPS growth 126.9%, 3Y rev CAGR 15.7%
- +100.7% vs DLB's -28.3%
DLB carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.79, yield 2.5%
- Lower volatility, beta 0.79, Low D/E 1.5%, current ratio 3.17x
- Beta 0.79, yield 2.5%, current ratio 3.17x
- 5.9% revenue growth vs BAC's -0.5%
JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs VVX's 251.6%
- PEG 0.81 vs DLB's 3.94
- NIM 2.2% vs BAC's 1.8%
- Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
KO is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 27.8% margin vs VVX's 1.9%
- 13.1% ROA vs BAC's 0.9%, ROIC 15.8% vs 3.5%
Among these 5 stocks, BAC doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.9% revenue growth vs BAC's -0.5% | |
| Value | Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26 | |
| Quality / Margins | 27.8% margin vs VVX's 1.9% | |
| Stability / Safety | Beta 0.79 vs JPM's 0.94, lower leverage | |
| Dividends | 2.5% yield, 12-year raise streak, vs KO's 2.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +100.7% vs DLB's -28.3% | |
| Efficiency (ROA) | 13.1% ROA vs BAC's 0.9%, ROIC 15.8% vs 3.5% |
VVX vs DLB vs JPM vs KO vs BAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VVX vs DLB vs JPM vs KO vs BAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
VVX leads 0 • DLB leads 0 • KO leads 0 • BAC leads 0 • 5 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — VVX and KO each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 209.4x DLB's $1.3B. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to VVX's 1.9%. On growth, VVX holds the edge at +23.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.7B | $1.3B | $280.3B | $49.3B | $191.6B |
| EBITDAEarnings before interest/tax | $289M | $352M | $81.4B | $15.5B | $40.0B |
| Net IncomeAfter-tax profit | $89M | $241M | $57.0B | $13.7B | $30.5B |
| Free Cash FlowCash after capex | $136M | $380M | $100.9B | $12.6B | $12.6B |
| Gross MarginGross profit ÷ Revenue | +8.5% | +87.9% | +60.0% | +61.7% | +56.1% |
| Operating MarginEBIT ÷ Revenue | +4.3% | +18.8% | +25.9% | +29.3% | +19.7% |
| Net MarginNet income ÷ Revenue | +1.9% | +18.0% | +20.4% | +27.8% | +15.9% |
| FCF MarginFCF ÷ Revenue | +2.9% | +28.4% | +36.0% | +25.5% | +6.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +23.4% | -2.9% | — | +12.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +140.0% | -21.4% | +16.0% | +18.2% | +18.3% |
Valuation Metrics
Evenly matched — VVX and JPM and BAC each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 60% valuation discount to VVX's 37.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs DLB's 6.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.8B | $5.0B | $896.0B | $355.6B | $422.8B |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $4.4B | $1.50T | $390.8B | $556.8B |
| Trailing P/EPrice ÷ TTM EPS | 37.07x | 20.05x | 16.00x | 27.18x | 14.66x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.91x | 12.19x | 14.40x | 25.27x | 12.56x |
| PEG RatioP/E ÷ EPS growth rate | — | 6.48x | 0.90x | 2.43x | 0.95x |
| EV / EBITDAEnterprise value multiple | 11.88x | 11.98x | 18.36x | 26.39x | 13.92x |
| Price / SalesMarket cap ÷ Revenue | 0.63x | 3.72x | 3.20x | 7.42x | 2.21x |
| Price / BookPrice ÷ Book value/share | 2.66x | 1.95x | 2.47x | 10.40x | 1.39x |
| Price / FCFMarket cap ÷ FCF | 16.72x | 11.66x | 8.88x | 67.15x | 33.52x |
Profitability & Efficiency
Evenly matched — DLB and KO each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $8 for VVX. DLB carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), VVX scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.2% | +9.2% | +15.9% | +41.1% | +10.1% |
| ROA (TTM)Return on assets | +2.7% | +7.5% | +1.3% | +13.1% | +0.9% |
| ROICReturn on invested capital | +7.7% | +10.1% | +4.5% | +15.8% | +3.5% |
| ROCEReturn on capital employed | +8.4% | +9.6% | +8.9% | +17.3% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.08x | 0.01x | 2.60x | 1.33x | 1.21x |
| Net DebtTotal debt minus cash | $801M | -$663M | $599.0B | $35.2B | $134.1B |
| Cash & Equiv.Liquid assets | $369M | $702M | $343.3B | $10.3B | $231.8B |
| Total DebtShort + long-term debt | $1.2B | $39M | $942.4B | $45.5B | $365.9B |
| Interest CoverageEBIT ÷ Interest expense | 3.50x | 65.71x | 0.74x | 10.70x | 0.48x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $5,794 for DLB. Over the past 12 months, VVX leads with a +100.7% total return vs DLB's -28.3%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs DLB's -12.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +63.4% | -16.2% | -0.5% | +20.3% | +1.1% |
| 1-Year ReturnPast 12 months | +100.7% | -28.3% | +21.8% | +17.2% | +28.1% |
| 3-Year ReturnCumulative with dividends | +96.6% | -33.0% | +138.2% | +47.0% | +103.0% |
| 5-Year ReturnCumulative with dividends | +67.2% | -42.1% | +118.2% | +65.6% | +47.1% |
| 10-Year ReturnCumulative with dividends | +251.6% | +32.2% | +465.8% | +121.1% | +368.2% |
| CAGR (3Y)Annualised 3-year return | +25.3% | -12.5% | +33.6% | +13.7% | +26.6% |
Risk & Volatility
Evenly matched — VVX and KO each lead in 1 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VVX currently trades 99.1% from its 52-week high vs DLB's 68.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.85x | 0.79x | 0.94x | -0.20x | 0.86x |
| 52-Week HighHighest price in past year | $91.64 | $77.00 | $337.25 | $84.04 | $57.55 |
| 52-Week LowLowest price in past year | $43.80 | $51.78 | $262.71 | $65.35 | $43.66 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +68.2% | +95.1% | +98.3% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 81.8 | 33.1 | 59.1 | 60.6 | 68.3 |
| Avg Volume (50D)Average daily shares traded | 471K | 675K | 7.0M | 12.7M | 31.7M |
Analyst Outlook
Evenly matched — DLB and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VVX as "Buy", DLB as "Buy", JPM as "Buy", KO as "Buy", BAC as "Buy". Consensus price targets imply 72.0% upside for DLB (target: $90) vs -13.4% for VVX (target: $79). For income investors, DLB offers the higher dividend yield at 2.47% vs JPM's 1.86%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $78.60 | $90.33 | $339.75 | $86.13 | $61.13 |
| # AnalystsCovering analysts | 19 | 17 | 61 | 48 | 54 |
| Dividend YieldAnnual dividend ÷ price | — | +2.5% | +1.9% | +2.5% | +2.3% |
| Dividend StreakConsecutive years of raises | — | 12 | 15 | 56 | 12 |
| Dividend / ShareAnnual DPS | — | $1.30 | $5.95 | $2.04 | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +3.2% | +3.9% | +0.2% | +5.1% |
JPM leads in 1 of 6 categories — strongest in Total Returns. 5 categories are tied.
VVX vs DLB vs JPM vs KO vs BAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VVX or DLB or JPM or KO or BAC a better buy right now?
For growth investors, Dolby Laboratories, Inc.
(DLB) is the stronger pick with 5. 9% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate V2X, Inc. (VVX) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VVX or DLB or JPM or KO or BAC?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus V2X, Inc. at 37. 1x. On forward P/E, Dolby Laboratories, Inc. is actually cheaper at 12. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Dolby Laboratories, Inc. 's 3. 94x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VVX or DLB or JPM or KO or BAC?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -42. 1% for Dolby Laboratories, Inc. (DLB). Over 10 years, the gap is even starker: JPM returned +465. 8% versus DLB's +32. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VVX or DLB or JPM or KO or BAC?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -571% more volatile than KO relative to the S&P 500. On balance sheet safety, Dolby Laboratories, Inc. (DLB) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — VVX or DLB or JPM or KO or BAC?
By revenue growth (latest reported year), Dolby Laboratories, Inc.
(DLB) is pulling ahead at 5. 9% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: V2X, Inc. grew EPS 126. 9% year-over-year, compared to -2. 6% for Dolby Laboratories, Inc.. Over a 3-year CAGR, VVX leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VVX or DLB or JPM or KO or BAC?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus 1. 7% for V2X, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 4. 3% for VVX. At the gross margin level — before operating expenses — DLB leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VVX or DLB or JPM or KO or BAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Dolby Laboratories, Inc. 's 3. 94x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Dolby Laboratories, Inc. (DLB) trades at 12. 2x forward P/E versus 25. 3x for The Coca-Cola Company — 13. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DLB: 72. 0% to $90. 33.
08Which pays a better dividend — VVX or DLB or JPM or KO or BAC?
In this comparison, DLB (2.
5% yield), KO (2. 5% yield), BAC (2. 3% yield), JPM (1. 9% yield) pay a dividend. VVX does not pay a meaningful dividend and should not be held primarily for income.
09Is VVX or DLB or JPM or KO or BAC better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, VVX: +251. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VVX and DLB and JPM and KO and BAC?
These companies operate in different sectors (VVX (Industrials) and DLB (Technology) and JPM (Financial Services) and KO (Consumer Defensive) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VVX is a small-cap quality compounder stock; DLB is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock; BAC is a large-cap deep-value stock. DLB, JPM, KO, BAC pay a dividend while VVX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.